Engineers Gate Manager LP

Position in OGN — Organon & Co.

CIK 1620220 NEW YORK, NY

Position in OGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$713,449

-$504,829 QoQ

Shares Held

52,692

-53.8% QoQ

Ownership

0.020%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#167

of 626 holders

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Engineers Gate Manager LP holds $31,594,540 across 11 Drug Manufacturers - General names. OGN ranks #6 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	112,886	$14,262,017
2	LLY	ELI LILLY & Co	6,562	$7,870,660
3	NVS	Novartis AG	28,899	$4,529,051
4	ABBV	AbbVie Inc.	4,125	$1,038,015
5	JNJ	Johnson & Johnson	3,449	$875,942
6	OGN	Organon & Co. This page	52,692	$713,449
7	AZN	Astrazeneca PLC	3,235	$613,420
8	NVO	Novo Nordisk A S	9,751	$467,462

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$713,449	52,692	-53.8%	Shares	Sole	2026-08-14
2025-09-30	$1,218,278	114,071	-22.3%	Shares	Sole	2025-11-14
2025-06-30	$1,420,675	146,764	+18.5%	Shares	Sole	2025-08-14
2025-03-31	$1,844,334	123,864	+132.9%	Shares	Sole	2025-05-15
2024-12-31	$793,326	53,172	-33.0%	Shares	Sole	2025-02-14
2024-09-30	$1,517,755	79,339	+9.9%	Shares	Sole	2024-11-14
2024-03-31	$1,357,078	72,185	+43.6%	Shares	Sole	2024-05-15
2023-12-31	$725,052	50,281	-64.3%	Shares	Sole	2024-02-14
2023-09-30	$2,445,885	140,892	+175.4%	Shares	Sole	2023-11-14
2023-06-30	$1,064,535	51,155	-31.5%	Shares	Sole	2023-08-14
2022-09-30	$1,747,605	74,684	+205.2%	Shares	Sole	2022-11-14
2022-06-30	$825,795	24,468	+115.3%	Shares	Sole	2022-08-15
2022-03-31	$397,049	11,367	-92.3%	Shares	Sole	2022-05-16
2021-12-31	$4,515,826	148,303	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.